A Randomized Controlled Trial Comparing Adjuvanted vs. Nonadjuvanted Influenza Vaccine in Adult Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients.
Phase of Trial: Phase IV
Latest Information Update: 12 Apr 2017
At a glance
- Drugs Influenza virus vaccine (Primary) ; GSK 1536489A
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 06 Apr 2017 Status changed from not yet recruiting to completed.
- 01 Oct 2015 New trial record